Announcements and Notices - [Other - Business Update]

CANbridge Pharmaceuticals operates as a global biopharmaceutical company. The Company focuses on developing and commercialising therapeutics for treatment of orphan diseases and rare cancers. CANbridge Pharmaceuticals serves customers worldwide.

Voluntary Announcement Update On The Group'S Business Operations In The United States

Voluntary Announcement - 
Announcement Of The Grant Of Priority Review Status Of
Can103 For The Treatment Of Gaucher Disease (Gd)

Announcements and Notices - [List of Directors and their Role and Function]

List Of Directors And Their Roles And Functions

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Remuneration Committee Member]

Appointment And Resignation Of Non-Executive Director
Change In Composition Of Board Committee

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CANbridge Pharmaceuticals (1228 HK)

Voluntary Announcement Update On The Group'S Business Operations In The United States

Voluntary Announcement - Announcement Of The Grant Of Priority Review Status Of Can103 For The Treatment Of Gaucher Disease (Gd)

List Of Directors And Their Roles And Functions

Appointment And Resignation Of Non-Executive Director Change In Composition Of Board Committee

Resignation Of Chief Financial Officer

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)